In vivo activation of leukocyte GPR120/FFAR4 by PUFAs has minimal impact on atherosclerosis in LDL receptor knockout mice

Journal of Lipid Research

Volumn 58, Issue 1, 2017, Pages 236-246

  Shewale, Swapnil V ^a   Brown, Amanda L ^a   Bi, Xin ^a   Boudyguina, Elena ^a   Sawyer, Janet K ^a   Alexander Miller, Martha A ^a   Parks, John S ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

G protein coupled receptor 120 free fatty acid receptor 4; G proteins; Inflammation; Low density lipoprotein; Macrophages monocytes; Omega 3 fatty acids; Polyunsaturated fatty acids; Supplementary fatty acid

Indexed keywords

BORAGE OIL; ECHIUM OIL; G PROTEIN COUPLED RECEPTOR 120; LOW DENSITY LIPOPROTEIN RECEPTOR; OMEGA 3 FATTY ACID; PALM OIL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VEGETABLE OIL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; CHOLESTEROL; G PROTEIN COUPLED RECEPTOR; O3FAR1 PROTEIN, MOUSE; OMEGA 6 FATTY ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BONE MARROW TRANSPLANTATION; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; IN VIVO STUDY; LIMIT OF QUANTITATION; MONOCYTE; MONOCYTOSIS; MOUSE; NONHUMAN; PROTEIN FUNCTION; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; AORTA; ATHEROGENIC DIET; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INFLAMMATION; KNOCKOUT MOUSE; LEUKOCYTE; METABOLISM; PATHOLOGY; TRANSCRIPTION INITIATION;

ANIMALS; AORTA; ATHEROSCLEROSIS; CHOLESTEROL; DIET, ATHEROGENIC; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LEUKOCYTES; MICE; MICE, KNOCKOUT; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LDL; TRANSCRIPTIONAL ACTIVATION;

EID: 85009739663     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M072769     Document Type: Article

References (53)

1. Wellendorph, P., L. D. Johansen, and H. Brauner-Osborne. 2009. Molecular pharmacology of promiscuous seven transmembrane receptors sensing organic nutrients. Mol. Pharmacol. 76: 453-465.
2. Briscoe, C. P., M. Tadayyon, J. L. Andrews, W. G. Benson, J. K. Chambers, M. M. Eilert, C. Ellis, N. A. Elshourbagy, A. S. Goetz, D. T. Minnick, et al. 2003. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J. Biol. Chem. 278: 11303-11311.
3. Brown, A. J., S. M. Goldsworthy, A. A. Barnes, M. M. Eilert, L. Tcheang, D. Daniels, A. I. Muir, M. J. Wigglesworth, I. Kinghorn, N. J. Fraser, et al. 2003. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278: 11312-11319.
4. Hirasawa, A., K. Tsumaya, T. Awaji, S. Katsuma, T. Adachi, M. Yamada, Y. Sugimoto, S. Miyazaki, and G. Tsujimoto. 2005. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat. Med. 11: 90-94.
5. Oh, D. Y., and J. M. Olefsky. 2012. Omega 3 fatty acids and GPR120. Cell Metab. 15: 564-565.
6. Wang, J., X. Wu, N. Simonavicius, H. Tian, and L. Ling. 2006. Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84. J. Biol. Chem. 281: 34457-34464.
7. Oh, D. Y., S. Talukdar, E. J. Bae, T. Imamura, H. Morinaga, W. Fan, P. Li, W. J. Lu, S. M. Watkins, and J. M. Olefsky. 2010. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 142: 687-698.
8. Ichimura, A., A. Hirasawa, O. Poulain-Godefroy, A. Bonnefond, T. Hara, L. Yengo, I. Kimura, A. Leloire, N. Liu, K. Iida, et al. 2012. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature. 483: 350-354.
9. Oh, D. Y., E. Walenta, T. E. Akiyama, W. S. Lagakos, D. Lackey, A. R. Pessentheiner, R. Sasik, N. Hah, T. J. Chi, J. M. Cox, et al. 2014. A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice. Nat. Med. 20: 942-947.
10. Bigger, J. T., Jr., and T. El-Sherif. 2001. Polyunsaturated fatty acids and cardiovascular events: a fish tale. Circulation. 103: 623-625.
11. Calder, P. C., and R. F. Grimble. 2002. Polyunsaturated fatty acids, inflammation and immunity. Eur. J. Clin. Nutr. 56(Suppl 3): S14-S19.
12. Kang, J. X., and A. Leaf. 1996. Antiarrhythmic effects of polyunsaturated fatty acids. Recent studies. Circulation. 94: 1774-1780.
13. Parks, J. S., J. Kaduck-Sawyer, B. C. Bullock, and L. L. Rudel. 1990. Effect of dietary fish oil on coronary artery and aortic atherosclerosis in African green monkeys. Arteriosclerosis. 10: 1102-1112.
14. Hu, F. B., L. Bronner, W. C. Willett, M. J. Stampfer, K. M. Rexrode, C. M. Albert, D. Hunter, and J. E. Manson. 2002. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA. 287: 1815-1821.
15. Harris, W. S., D. Mozaffarian, E. Rimm, P. Kris-Etherton, L. L. Rudel, L. J. Appel, M. M. Engler, M. B. Engler, and F. Sacks. 2009. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation. 119: 902-907.
16. Harris, W. S., and G. C. Shearer. 2014. Omega-6 fatty acids and cardiovascular disease: friend, not foe? Circulation. 130: 1562-1564.
17. Farvid, M. S., M. Ding, A. Pan, Q. Sun, S. E. Chiuve, L. M. Steffen, W. C. Willett, and F. B. Hu. 2014. Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies. Circulation. 130: 1568-1578.
18. Brown, A. L., X. Zhu, S. Rong, S. Shewale, J. Seo, E. Boudyguina, A. K. Gebre, M. A. Alexander-Miller, and J. S. Parks. 2012. Omega-3 fatty acids ameliorate atherosclerosis by favorably altering monocyte subsets and limiting monocyte recruitment to aortic lesions. Arterioscler. Thromb. Vasc. Biol. 32: 2122-2130.
19. Zampolli, A., A. Bysted, T. Leth, A. Mortensen, R. De Caterina, and E. Falk. 2006. Contrasting effect of fish oil supplementation on the development of atherosclerosis in murine models. Atherosclerosis. 184: 78-85.
20. Parks, J. S., and L. L. Rudel. 1990. Effect of fish oil on atherosclerosis and lipoprotein metabolism. Atherosclerosis. 84: 83-94.
21. Harris, W. S. 1989. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J. Lipid Res. 30: 785-807.
22. Bell 3rd, T. A., K. Kelley, M. D. Wilson, J. K. Sawyer, and L. L. Rudel. 2007. Dietary fat-induced alterations in atherosclerosis are abolished by ACAT2-deficiency in ApoB100 only, LDLr-/- mice. Arterioscler. Thromb. Vasc. Biol. 27: 1396-1402.
23. Rudel, L. L., F. L. Johnson, J. K. Sawyer, M. S. Wilson, and J. S. Parks. 1995. Dietary polyunsaturated fat modifies low-density lipoproteins and reduces atherosclerosis of nonhuman primates with high and low diet responsiveness. Am. J. Clin. Nutr. 62: 463S-470S.
24. Rudel, L. L., J. S. Parks, and J. K. Sawyer. 1995. Compared with dietary monounsaturated and saturated fat, polyunsaturated fat protects African green monkeys from coronary artery atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15: 2101-2110.
25. Thornburg, J. T., J. S. Parks, and L. L. Rudel. 1995. Dietary fatty acid modification of HDL phospholipid molecular species alters lecithin: cholesterol acyltransferase reactivity in cynomolgus monkeys. J. Lipid Res. 36: 277-289.
26. Rett, B. S., and J. Whelan. 2011. Increasing dietary linoleic acid does not increase tissue arachidonic acid content in adults consuming Western-type diets: a systematic review. Nutr. Metab. (Lond.). 8: 36.
27. Demmelmair, H., B. Iser, A. Rauh-Pfeiffer, and B. Koletzko. 1999. Comparison of bolus versus fractionated oral applications of [13C]- linoleic acid in humans. Eur. J. Clin. Invest. 29: 603-609.
28. Hussein, N., E. Ah-Sing, P. Wilkinson, C. Leach, B. A. Griffin, and D. J. Millward. 2005. Long-chain conversion of [13C]linoleic acid and alpha-linolenic acid in response to marked changes in their dietary intake in men. J. Lipid Res. 46: 269-280.
29. Chopra, J., and R. O. Webster. 1988. PGE1 inhibits neutrophil adherence and neutrophil-mediated injury to cultured endothelial cells. Am. Rev. Respir. Dis. 138: 915-920.
30. Jones, D. A., and F. A. Fitzpatrick. 1990. "Suicide" inactivation of thromboxane A2 synthase. Characteristics of mechanism-based inactivation with isolated enzyme and intact platelets. J. Biol. Chem. 265: 20166-20171.
31. Shewale, S. V., E. Boudyguina, X. Zhu, L. Shen, P. M. Hutchins, R. M. Barkley, R. C. Murphy, and J. S. Parks. 2015. Botanical oils enriched in n-6 and n-3 FADS2 products are equally effective in preventing atherosclerosis and fatty liver. J. Lipid Res. 56: 1191-1205.
32. Rudel, L. L., K. Kelley, J. K. Sawyer, R. Shah, and M. D. Wilson. 1998. Dietary monounsaturated fatty acids promote aortic atherosclerosis in LDL receptor-null, human ApoB100-overexpressing transgenic mice. Arterioscler. Thromb. Vasc. Biol. 18: 1818-1827.
33. Zhang, P., E. Boudyguina, M. D. Wilson, A. K. Gebre, and J. S. Parks. 2008. Echium oil reduces plasma lipids and hepatic lipogenic gene expression in apoB100-only LDL receptor knockout mice. J. Nutr. Biochem. 19: 655-663.
34. Rong, S., Q. Cao, M. Liu, J. Seo, L. Jia, E. Boudyguina, A. K. Gebre, P. L. Colvin, T. L. Smith, R. C. Murphy, et al. 2012. Macrophage 12/15 lipoxygenase expression increases plasma and hepatic lipid levels and exacerbates atherosclerosis. J. Lipid Res. 53: 686-695.
35. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
36. Zhu, X., J. Y. Lee, J. M. Timmins, J. M. Brown, E. Boudyguina, A. Mulya, A. K. Gebre, M. C. Willingham, E. M. Hiltbold, N. Mishra, et al. 2008. Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages. J. Biol. Chem. 283: 22930-22941.
37. Carr, T. P., C. J. Andresen, and L. L. Rudel. 1993. Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin. Biochem. 26: 39-42.
38. Galkina, E., A. Kadl, J. Sanders, D. Varughese, I. J. Sarembock, and K. Ley. 2006. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J. Exp. Med. 203: 1273-1282.
39. Tacke, F., F. Ginhoux, C. Jakubzick, N. van Rooijen, M. Merad, and G. J. Randolph. 2006. Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery. J. Exp. Med. 203: 583-597.
40. Tacke, F., D. Alvarez, T. J. Kaplan, C. Jakubzick, R. Spanbroek, J. Llodra, A. Garin, J. Liu, M. Mack, N. van Rooijen, et al. 2007. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 117: 185-194.
41. Daugherty, A., and S. C. Whitman. 2003. Quantification of atherosclerosis in mice. Methods Mol. Biol. 209: 293-309.
42. Drechsler, M., R. T. Megens, M. van Zandvoort, C. Weber, and O. Soehnlein. 2010. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation. 122: 1837-1845.
43. Swirski, F. K., P. Libby, E. Aikawa, P. Alcaide, F. W. Luscinskas, R. Weissleder, and M. J. Pittet. 2007. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J. Clin. Invest. 117: 195-205.
44. Swirski, F. K., M. Nahrendorf, M. Etzrodt, M. Wildgruber, V. Cortez- Retamozo, P. Panizzi, J. L. Figueiredo, R. H. Kohler, A. Chudnovskiy, P. Waterman, et al. 2009. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 325: 612-616.
45. Geissmann, F., M. G. Manz, S. Jung, M. H. Sieweke, M. Merad, and K. Ley. 2010. Development of monocytes, macrophages, and dendritic cells. Science. 327: 656-661.
46. Bjursell, M., X. Xu, T. Admyre, G. Bottcher, S. Lundin, R. Nilsson, V. M. Stone, N. G. Morgan, Y. Y. Lam, L. H. Storlien, et al. 2014. The beneficial effects of n-3 polyunsaturated fatty acids on diet induced obesity and impaired glucose control do not require Gpr120. PLoS One. 9: e114942.
47. Lusis, A. J. 2000. Atherosclerosis. Nature. 407: 233-241.
48. VanderLaan, P. A., C. A. Reardon, R. A. Thisted, and G. S. Getz. 2009. VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice. J. Lipid Res. 50: 376-385.
49. Robbins, C. S., I. Hilgendorf, G. F. Weber, I. Theurl, Y. Iwamoto, J-L. Figueiredo, R. Gorbatov, G. K. Sukhova, L. M. S. Gerhardt, D. Smyth, et al. 2013. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat. Med. 19: 1166-1172.
50. Hashimoto, D., A. Chow, C. Noizat, P. Teo, M. B. Beasley, M. Leboeuf, C. D. Becker, P. See, J. Price, D. Lucas, et al. 2013. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity. 38: 792-804.
51. Randolph, G. J. 2013. Proliferating macrophages prevail in atherosclerosis. Nat. Med. 19: 1094-1095.
52. Bi, X., X. Zhu, C. Gao, S. Shewale, Q. Cao, M. Liu, E. Boudyguina, A. K. Gebre, M. D. Wilson, A. L. Brown, et al. 2014. Myeloid cell-specific ATP-binding cassette transporter A1 deletion has minimal impact on atherogenesis in atherogenic diet-fed low-density lipoprotein receptor knockout mice. Arterioscler. Thromb. Vasc. Biol. 34: 1888-1899.
53. Suckow, A. T., D. Polidori, W. Yan, S. Chon, J. Y. Ma, J. Leonard, and C. P. Briscoe. 2014. Alteration of the glucagon axis in GPR120 (FFAR4) knockout mice: a role for GPR120 in glucagon secretion. J. Biol. Chem. 289: 15751-15763.